Advertisement
CCM vs THC
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CCM is a Hold and THC is a Buy.
CCM sees its Stochastic Oscillator climbs out of oversold territory
On November 03, 2026, the Stochastic Oscillator for CCM moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 72 instances where the indicator left the oversold zone. In 68 of the 72 cases the stock moved higher in the following days. This puts the odds of a move higher at over 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
Following a +4.78% 3-day Advance, the price is estimated to grow further. Considering data from situations where CCM advanced for three days, in 133 of 161 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on November 11, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CCM as a result. In 127 of 144 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 88%.
The Moving Average Convergence Divergence Histogram (MACD) for CCM turned negative on November 11, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 66 similar instances when the indicator turned negative. In 55 of the 66 cases the stock turned lower in the days that followed. This puts the odds of success at 83%.
CCM moved below its 50-day moving average on October 26, 2026 date and that indicates a change from an upward trend to a downward trend.
The 50-day moving average for CCM moved below the 200-day moving average on October 07, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CCM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.
The Aroon Indicator for CCM entered a downward trend on October 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 1 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-0.009) is normal, around the industry mean (204.532). P/E Ratio (-0.054) is within average values for comparable stocks, (21.572). Projected Growth (PEG Ratio) (0.130) is also within normal values, averaging (2.498). CCM has a moderately high Dividend Yield (1.067) as compared to the industry average of (0.154). P/S Ratio (0.249) is also within normal values, averaging (2.688).
The Tickeron PE Growth Rating for this company is 33 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 73 (best 1 - 100 worst), indicating slightly worse than average price growth. CCM’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CCM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
THC in +1.37% Uptrend, growing for three consecutive days on November 11, 2026
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where THC advanced for three days, in 266 of 324 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on November 04, 2026. You may want to consider a long position or call options on THC as a result. In 64 of 79 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 81%.
The Moving Average Convergence Divergence (MACD) for THC just turned positive on November 04, 2026. Looking at past instances where THC's MACD turned positive, the stock continued to rise in 34 of 44 cases over the following month. The odds of a continued upward trend are 77%.
THC moved above its 50-day moving average on October 28, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for THC crossed bullishly above the 50-day moving average on October 15, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 80%.
The Aroon Indicator entered an Uptrend today. In 214 of 264 cases where THC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 81%.
Bearish Trend Analysis
The 10-day RSI Indicator for THC moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 54 similar instances where the indicator moved out of overbought territory. In 34 of the 54 cases, the stock moved lower in the following days. This puts the odds of a move lower at 63%.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where THC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 66%.
THC broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is 10 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock better than average.
The Tickeron SMR rating for this company is 20 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 38 (best 1 - 100 worst), indicating steady price growth. THC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 68 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 69 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.898) is normal, around the industry mean (204.532). P/E Ratio (10.872) is within average values for comparable stocks, (21.572). Projected Growth (PEG Ratio) (1.789) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.154) among similar stocks. P/S Ratio (1.022) is also within normal values, averaging (2.688).
CCM | THC | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 8 | 31 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 1 Undervalued | 69 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 10 | |
SMR RATING 1..100 | 100 | 20 | |
PRICE GROWTH RATING 1..100 | 73 | 38 | |
P/E GROWTH RATING 1..100 | 33 | 68 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CCM's Valuation (1) in the Hospital Or Nursing Management industry is significantly better than the same rating for THC (69). This means that CCM’s stock grew significantly faster than THC’s over the last 12 months.
THC's Profit vs Risk Rating (10) in the Hospital Or Nursing Management industry is significantly better than the same rating for CCM (100). This means that THC’s stock grew significantly faster than CCM’s over the last 12 months.
THC's SMR Rating (20) in the Hospital Or Nursing Management industry is significantly better than the same rating for CCM (100). This means that THC’s stock grew significantly faster than CCM’s over the last 12 months.
THC's Price Growth Rating (38) in the Hospital Or Nursing Management industry is somewhat better than the same rating for CCM (73). This means that THC’s stock grew somewhat faster than CCM’s over the last 12 months.
CCM's P/E Growth Rating (33) in the Hospital Or Nursing Management industry is somewhat better than the same rating for THC (68). This means that CCM’s stock grew somewhat faster than THC’s over the last 12 months.
| CCM | THC | |
|---|---|---|
| RSI ODDS (%) | N/A | 2 days ago 63% |
| Stochastic ODDS (%) | 2 days ago 90% | 2 days ago 57% |
| Momentum ODDS (%) | 2 days ago 88% | 2 days ago 81% |
| MACD ODDS (%) | 2 days ago 83% | 2 days ago 77% |
| TrendWeek ODDS (%) | 2 days ago 89% | 2 days ago 80% |
| TrendMonth ODDS (%) | 2 days ago 89% | 2 days ago 78% |
| Advances ODDS (%) | 4 days ago 83% | 2 days ago 82% |
| Declines ODDS (%) | 2 days ago 88% | 7 days ago 66% |
| BollingerBands ODDS (%) | N/A | 2 days ago 56% |
| Aroon ODDS (%) | 2 days ago 90% | 2 days ago 81% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CCM’s FA Score shows that 2 FA rating(s) are green while THC’s FA Score has 2 green FA rating(s).
- CCM’s FA Score: 2 green, 3 red.
- THC’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CCM’s TA Score shows that 2 TA indicator(s) are bullish while THC’s TA Score has 6 bullish TA indicator(s).
- CCM’s TA Score: 2 bullish, 6 bearish.
- THC’s TA Score: 6 bullish, 4 bearish.
Price Growth
CCM (@Hospital/Nursing Management) experienced а -5.95% price change this week, while THC (@Hospital/Nursing Management) price change was +0.25% for the same time period.
The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was -5.72%. For the same industry, the average monthly price growth was +0.44%, and the average quarterly price growth was +11.06%.
Reported Earning Dates
THC is expected to report earnings on Feb 11, 2027.
Industries' Descriptions
@Hospital/Nursing Management (-5.72% weekly)Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.
Advertisement
CCM and
Correlation & Price change
A.I.dvisor tells us that CCM and NAKA have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CCM and NAKA's prices will move in lockstep.
THC and
Correlation & Price change
A.I.dvisor indicates that over the last year, THC has been loosely correlated with HCA. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if THC jumps, then HCA could also see price increases.